<DOC>
	<DOCNO>NCT02384590</DOCNO>
	<brief_summary>Patients sickle cell disease ( SCD ) experience significant depressive symptom currently go unrecognized under-treated . Further , depression patient population potential contribute high health care utilization poor disease outcome ; however , currently comparative effectiveness study evidenced-based mental health treatment depression SCD . The primary objective study test effectiveness online computerize cognitive behavioral therapy intervention address psychological behavioral need patient sickle cell disease , namely depression pain symptom . The investigator implement exist computerize cognitive behavioral therapy ( CCBT ) program call `` Beating Blues '' routine clinical care University Pittsburgh Medical Center ( UPMC ) Adult Sickle Cell Clinic determine effectiveness intervention decrease depression pain versus treatment usual . Patients significant distress—depression and/or anxiety symptoms—will randomize either eight session CCBT program weekly follow-up care manager treatment usual treating physician notify patient 's symptom . The investigator evaluate patient acceptability , implementation practicality online mental health intervention patient use site ( frequency duration visit ) , qualitative interview , survey . The investigator hypothesize : 1 ) CCBT acceptable mental health treatment patient easily integrated routine clinical care ; 2 ) patient treatment arm show great decrease depression/anxiety symptom average daily pain patient usual care .</brief_summary>
	<brief_title>Cognitive Behavioral Therapy Real-time Self-management Intervention SCD Via Mobile Applications</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>1 . Male female ≥18 year age baseline visit . 2 . Documentation SCD diagnosis ( HgbSS , HgbSC , SBeta +Thal ; SBeta oThal ) 3 . Receive routine care UPMC sickle cell clinic . 4 . Scores indicative clinically significant depression anxiety stress/pain screener administer part routine SCD care patient . i.e . Patient Health Questionnaire ( PHQ9 ) ≥ 10 and/or Generalized Anxiety Disorder scale ( GAD7 ) ≥ 8 1 . Presence condition abnormality ( e.g . significant neurocognitive dysfunction ) opinion Investigator would compromise safety patient quality data .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>